Neurodegenerative Disease Biomarkers

Neurodegenerative disease biomarkers have emerged as crucial tools in the early diagnosis, monitoring, and treatment of disorders such as Alzheimer's, Parkinson's, and Huntington's diseases. Advances in biomarker research have led to the identification of various molecular and imaging markers that reflect the underlying pathological processes of these diseases. Biomarkers such as amyloid-beta and tau proteins in cerebrospinal fluid (CSF) and blood are pivotal in diagnosing Alzheimer's disease at preclinical stages. Similarly, alpha-synuclein and neurofilament light chain (NfL) have shown promise in detecting Parkinson's disease and other neurodegenerative conditions. These biomarkers not only aid in early diagnosis but also in tracking disease progression and response to therapies. Imaging biomarkers, including PET and MRI scans, provide non-invasive methods to visualize brain changes and monitor the effects of therapeutic interventions. The integration of these biomarkers in clinical practice enhances the precision of neurodegenerative disease management, offering hope for improved patient outcomes and the development of targeted therapies.

    Related Conference of Neurodegenerative Disease Biomarkers

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Neurodegenerative Disease Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in